Simon Roberts

Simon Roberts
T: +44 (0) 20 7246 0522
E: simon.roberts@alantra.com

Simon is a Vice President at Alantra and has over five years’ corporate finance experience.

He works alongside our Partners and Directors to deliver all types of deals including company acquisitions and disposals, management buy-outs (MBOs), fund raisings and strategic reviews, acting for business owners, management teams, corporates and private equity.​ 

Recent deals include the sales of UK Heating Group and CP Electronics, the secondary management buy-out of Alcumus, the growth capital investment in Coryton Advanced Fuels, the sale via a management buy-out of Aqualisa, the minority investment in Efficio and the acquisition of Santia by Alcumus.

Simon graduated from Cardiff University with a First Class Honours Degree in Business Management. He qualified as a chartered accountant at Ernst & Young and has worked across both their Restructuring and Debt Advisory teams.

Outside of work Simon enjoys winter sports, travel and rugby union.

Alantra appoints experienced partner to head up its UK Real Estate & Hospitality team

Alantra has appointed Hoong Wey Woon as a Partner to head up its UK Real Estate & Hospitality team.  

Alantra advises Strong Roots on securing over €15.5m of investment

Alantra advises Strong Roots, one of the UK’s fastest-growing food companies, on securing over €15.5m of investment 

Alantra advises i2S on its sale to Gfi Informatique

Alantra advises Portuguese IT firm, i2S, on its sale to Gfi Informatique 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.